GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » The Chemours Co (NYSE:CC) » Definitions » 3-Year Sharpe Ratio

CC (The Chemours Co) 3-Year Sharpe Ratio : -0.60 (As of Jul. 01, 2025)


View and export this data going back to 2015. Start your Free Trial

What is The Chemours Co 3-Year Sharpe Ratio?

The 3-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past three years. As of today (2025-07-01), The Chemours Co's 3-Year Sharpe Ratio is -0.60.

Competitive Comparison of The Chemours Co's 3-Year Sharpe Ratio

For the Specialty Chemicals subindustry, The Chemours Co's 3-Year Sharpe Ratio, along with its competitors' market caps and 3-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Chemours Co's 3-Year Sharpe Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, The Chemours Co's 3-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where The Chemours Co's 3-Year Sharpe Ratio falls into.


;
;

The Chemours Co 3-Year Sharpe Ratio Calculation

The 3-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last three years. A stock / portfolio's 3-Year Sharpe Ratio can be calculated by dividing the difference between the three-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past three years.

The Chemours Co  (NYSE:CC) 3-Year Sharpe Ratio Explanation

The 3-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past three years. It is calculated as the annualized result of the average three-year monthly excess returns divided by its standard deviation in the three-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

The Chemours Co 3-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of The Chemours Co's 3-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

The Chemours Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » The Chemours Co (NYSE:CC) » Definitions » 3-Year Sharpe Ratio
Comparable Companies
MTX NGVT KWR PRM IOSP CLMT SCL ASH ECVT ODC LIN XPAR:AI SHW ECL APD ISX:TPIA XSWX:GIVN XSWX:SIKA OCSE:NSIS B DD
Traded in Other Exchanges
CC:Mexico 0HWG:UK 2CU:Germany CHEM:Austria
Address
1007 Market Street, Wilmington, DE, USA, 19801
Website
https://www.chemours.com
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
Executives
Alvenia Scarborough officer: SVP Corp Communications & CBO C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Ron Christopher Charles officer: Senior Vice President, People C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sandra Phillips Rogers director 1000 CRANBERRY WOODS DRIVE, CRANBERRY TOWNSHIP PA 16066
Erin N Kane director 300 KIMBALL DRIVE, SUITE 101, PARSIPPANY NJ 07054
Joseph T. Martinko officer: President, Thermal & Specializ C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Mark Newman officer: Senior Vice President and CFO 1011 WARRENVILLE ROAD, SUITE 600, LISLE IL 60532
Matthew S Abbott officer: SVP, Chief Enterprise Transfor C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Guillaume Pepy director C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sean D Keohane director C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Calderon Gerardo Familiar officer: Pres Advanced Performance Mat C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Alisha Bellezza officer: President, Thermal Spec Solns C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Camela Wisel officer: VP, CAO & Controller C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sameer Ralhan officer: SVP, CFO C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19899
Jonathan Lock officer: SVP, Chief Development Officer C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Susan M. Kelliher officer: SVP, People and Health Service ALBEMARLE CORPORATION, 451 FLORIDA STREET, BATON ROUGE LA 70801